Avidity biosciences to participate in upcoming investor conferences

La jolla, calif. , aug. 31, 2021 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna) a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that the avidity management team will be participating at the following conferences: 2021 wells fargo virtual healthcare conference september 9 th, 2021 11:20am et – fireside chat chardan virtual 5th annual genetic medicines conference october 5 th, 2021  12noon et – panel titled "rna-based targeted delivery approaches"  1:30pm et – fireside chat live webcasts of each event, as well as an archived replay of the webcasts following each event, will be available on the "events and presentations" page in the "investors" section of avidity's website at https://aviditybiosciences.investorroom.com/events-and-presentations.
RNA Ratings Summary
RNA Quant Ranking